HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Plasma exchange in catastrophic antiphospholipid syndrome.

Abstract
Plasma exchange is a well-established therapeutic procedure commonly used in many autoimmune disorders. The beneficial effects of plasma exchange are thought to occur through the elimination of pathogenic mediators found in plasma, including autoantibodies, complement components, and cytokines. The catastrophic antiphsopholipid syndrome (CAPS) is a life-threatening variant of the antiphospholipid syndrome (APS) where several thrombosis take place in a short period of time in patients with circulating antiphospholipid antibodies. The triple therapy with anticoagulation, corticosteroids and plasma exchange or intravenous immunoglobulins has been proposed in CAPS. CAPS is a rare disease precluding the conduction of formal clinical trials. However, the observation of a better clinical course of patients who received this treatment supports their use. Plasma exchange has become an established therapeutic procedure in CAPS but there are no studies regarding the better approach and thus its use relies on the experience of the physicians in charge. The current article aims to review potential mechanisms of action of plasma exchange and the technical aspects of this procedure and will focus on its current role in CAPS, the experience published in treating this condition and the treatment protocol that we use in our institution.
AuthorsIgnasi Rodríguez-Pintó, Miquel Lozano, Joan Cid, Gerard Espinosa, Ricard Cervera
JournalPresse medicale (Paris, France : 1983) (Presse Med) Vol. 48 Issue 11 Pt 2 Pg. 347-353 (Nov 2019) ISSN: 2213-0276 [Electronic] France
PMID31694791 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2019 Elsevier Masson SAS. All rights reserved.
Chemical References
  • Adrenal Cortex Hormones
  • Antibodies, Antiphospholipid
  • Anticoagulants
Topics
  • Adrenal Cortex Hormones (therapeutic use)
  • Antibodies, Antiphospholipid (blood)
  • Anticoagulants (therapeutic use)
  • Antiphospholipid Syndrome (blood, immunology, therapy)
  • Combined Modality Therapy (methods)
  • Fluid Therapy (methods)
  • Humans
  • Plasma Exchange (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: